Trinity compound research profile
Pinealon
Pinealon is a very short peptide made of just 3 amino acids (called EDR, after the first letters of those amino acids). It's described as coming from a...
Research overview
Pinealon is a very short peptide made of just 3 amino acids (called EDR, after the first letters of those amino acids). It's described as coming from a larger substance called Cortexin, a neuroprotective mixture. It belongs to a family of 'ultra-short peptide bioregulators' developed by a research program associated with the scientist Khavinson, based mainly in Russia (Khavinson et al., Molecules 2020).
Mechanism under study
The theory is that this tiny peptide can slip into cells, even into the cell's nucleus (control center), and directly interact with DNA and the proteins that package it (histones) — essentially acting like a dial that can turn certain genes up or down (J Phys Chem B 2019). Researchers have proposed it might turn on genes related to antioxidant protection (helping cells fight off damage) and turn down genes related to cell death, and it may also boost serotonin (a mood-related brain chemical) production in brain cells.
Human evidence summary
The available human evidence is limited and comes from open-label studies (meaning everyone knew they were getting the real treatment — there was no blind comparison group) rather than rigorous, gold-standard trials. One study involved 72 patients with lingering symptoms after brain injury or general mental fatigue, given oral Pinealon along with their standard treatment; they reportedly showed improved memory, less headache, and better performance on certain tests, along with a specific brainwave change (increased alpha activity on EEG) (Molecules 2020 review). No properly randomized, placebo-controlled human trial has been found, and the study didn't report detailed dosing or side-effect information.
Preclinical evidence summary
In rats, Pinealon reduced a marker of cell-death signaling (called caspase-3) in the brain and improved maze-learning performance under low-oxygen stress conditions, in both young and old rats (caspase-3 study; carotid-occlusion study). Most of the total evidence for this peptide — roughly 22 published studies — comes from one closely connected group of researchers rather than many independent labs.
Source material
Use the linked publications and records to evaluate study design, population, limitations, and relevance.